Cargando…

Activity of the Lactate Dehydrogenase Inhibitor Oxamic Acid against the Fermentative Bacterium Streptococcus mitis/oralis: Bactericidal Effects and Prevention of Daptomycin Resistance In Vitro and in an Ex Vivo Model

Streptococcus mitis/oralis is a fermentative bacterium that relies on lactate dehydrogenase to balance its redox poise and keep glycolysis active. Metabolomic analysis of an in vitro–derived daptomycin-resistant (DAP-R) S. mitis/oralis strain (351-D10) revealed differences in glucose catabolism rela...

Descripción completa

Detalles Bibliográficos
Autores principales: Kebriaei, Razieh, Bayer, Arnold S., Lapitan, Christian K., Rybak, Michael J., Somerville, Greg A., Mishra, Nagendra N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9598551/
https://www.ncbi.nlm.nih.gov/pubmed/36290066
http://dx.doi.org/10.3390/antibiotics11101409
_version_ 1784816361869934592
author Kebriaei, Razieh
Bayer, Arnold S.
Lapitan, Christian K.
Rybak, Michael J.
Somerville, Greg A.
Mishra, Nagendra N.
author_facet Kebriaei, Razieh
Bayer, Arnold S.
Lapitan, Christian K.
Rybak, Michael J.
Somerville, Greg A.
Mishra, Nagendra N.
author_sort Kebriaei, Razieh
collection PubMed
description Streptococcus mitis/oralis is a fermentative bacterium that relies on lactate dehydrogenase to balance its redox poise and keep glycolysis active. Metabolomic analysis of an in vitro–derived daptomycin-resistant (DAP-R) S. mitis/oralis strain (351-D10) revealed differences in glucose catabolism relative to its DAP-susceptible (DAP-S) parental strain, 351. Metabolic changes associated with the transition to this DAP-R phenotype suggested that inhibiting glycolysis could alter DAP susceptibility. In addition, the strong reliance of S. mitis/oralis on glycolysis for energy and biosynthetic intermediates suggested that inhibiting glycolysis would adversely affect growth and biomass accumulation. To test these hypotheses, we used the lactate dehydrogenase inhibitor oxamic acid (OXA) to assess its efficacy against DAP-S S. mitis/oralis strain 351 during DAP exposures in vitro and ex vivo. As expected, OXA was growth inhibitory to S. mitis/oralis in a dose-dependent manner in vitro; however, it did not alter in vitro DAP susceptibility profiles. In contrast, OXA did prevent the emergence of DAP-R in an ex vivo model of simulated endocardial vegetations. These data suggest that metabolic inhibitors directed against this fermentative bacterium with limited metabolic capabilities could enhance killing and potentially forestall the emergence of DAP resistance.
format Online
Article
Text
id pubmed-9598551
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-95985512022-10-27 Activity of the Lactate Dehydrogenase Inhibitor Oxamic Acid against the Fermentative Bacterium Streptococcus mitis/oralis: Bactericidal Effects and Prevention of Daptomycin Resistance In Vitro and in an Ex Vivo Model Kebriaei, Razieh Bayer, Arnold S. Lapitan, Christian K. Rybak, Michael J. Somerville, Greg A. Mishra, Nagendra N. Antibiotics (Basel) Article Streptococcus mitis/oralis is a fermentative bacterium that relies on lactate dehydrogenase to balance its redox poise and keep glycolysis active. Metabolomic analysis of an in vitro–derived daptomycin-resistant (DAP-R) S. mitis/oralis strain (351-D10) revealed differences in glucose catabolism relative to its DAP-susceptible (DAP-S) parental strain, 351. Metabolic changes associated with the transition to this DAP-R phenotype suggested that inhibiting glycolysis could alter DAP susceptibility. In addition, the strong reliance of S. mitis/oralis on glycolysis for energy and biosynthetic intermediates suggested that inhibiting glycolysis would adversely affect growth and biomass accumulation. To test these hypotheses, we used the lactate dehydrogenase inhibitor oxamic acid (OXA) to assess its efficacy against DAP-S S. mitis/oralis strain 351 during DAP exposures in vitro and ex vivo. As expected, OXA was growth inhibitory to S. mitis/oralis in a dose-dependent manner in vitro; however, it did not alter in vitro DAP susceptibility profiles. In contrast, OXA did prevent the emergence of DAP-R in an ex vivo model of simulated endocardial vegetations. These data suggest that metabolic inhibitors directed against this fermentative bacterium with limited metabolic capabilities could enhance killing and potentially forestall the emergence of DAP resistance. MDPI 2022-10-13 /pmc/articles/PMC9598551/ /pubmed/36290066 http://dx.doi.org/10.3390/antibiotics11101409 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Kebriaei, Razieh
Bayer, Arnold S.
Lapitan, Christian K.
Rybak, Michael J.
Somerville, Greg A.
Mishra, Nagendra N.
Activity of the Lactate Dehydrogenase Inhibitor Oxamic Acid against the Fermentative Bacterium Streptococcus mitis/oralis: Bactericidal Effects and Prevention of Daptomycin Resistance In Vitro and in an Ex Vivo Model
title Activity of the Lactate Dehydrogenase Inhibitor Oxamic Acid against the Fermentative Bacterium Streptococcus mitis/oralis: Bactericidal Effects and Prevention of Daptomycin Resistance In Vitro and in an Ex Vivo Model
title_full Activity of the Lactate Dehydrogenase Inhibitor Oxamic Acid against the Fermentative Bacterium Streptococcus mitis/oralis: Bactericidal Effects and Prevention of Daptomycin Resistance In Vitro and in an Ex Vivo Model
title_fullStr Activity of the Lactate Dehydrogenase Inhibitor Oxamic Acid against the Fermentative Bacterium Streptococcus mitis/oralis: Bactericidal Effects and Prevention of Daptomycin Resistance In Vitro and in an Ex Vivo Model
title_full_unstemmed Activity of the Lactate Dehydrogenase Inhibitor Oxamic Acid against the Fermentative Bacterium Streptococcus mitis/oralis: Bactericidal Effects and Prevention of Daptomycin Resistance In Vitro and in an Ex Vivo Model
title_short Activity of the Lactate Dehydrogenase Inhibitor Oxamic Acid against the Fermentative Bacterium Streptococcus mitis/oralis: Bactericidal Effects and Prevention of Daptomycin Resistance In Vitro and in an Ex Vivo Model
title_sort activity of the lactate dehydrogenase inhibitor oxamic acid against the fermentative bacterium streptococcus mitis/oralis: bactericidal effects and prevention of daptomycin resistance in vitro and in an ex vivo model
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9598551/
https://www.ncbi.nlm.nih.gov/pubmed/36290066
http://dx.doi.org/10.3390/antibiotics11101409
work_keys_str_mv AT kebriaeirazieh activityofthelactatedehydrogenaseinhibitoroxamicacidagainstthefermentativebacteriumstreptococcusmitisoralisbactericidaleffectsandpreventionofdaptomycinresistanceinvitroandinanexvivomodel
AT bayerarnolds activityofthelactatedehydrogenaseinhibitoroxamicacidagainstthefermentativebacteriumstreptococcusmitisoralisbactericidaleffectsandpreventionofdaptomycinresistanceinvitroandinanexvivomodel
AT lapitanchristiank activityofthelactatedehydrogenaseinhibitoroxamicacidagainstthefermentativebacteriumstreptococcusmitisoralisbactericidaleffectsandpreventionofdaptomycinresistanceinvitroandinanexvivomodel
AT rybakmichaelj activityofthelactatedehydrogenaseinhibitoroxamicacidagainstthefermentativebacteriumstreptococcusmitisoralisbactericidaleffectsandpreventionofdaptomycinresistanceinvitroandinanexvivomodel
AT somervillegrega activityofthelactatedehydrogenaseinhibitoroxamicacidagainstthefermentativebacteriumstreptococcusmitisoralisbactericidaleffectsandpreventionofdaptomycinresistanceinvitroandinanexvivomodel
AT mishranagendran activityofthelactatedehydrogenaseinhibitoroxamicacidagainstthefermentativebacteriumstreptococcusmitisoralisbactericidaleffectsandpreventionofdaptomycinresistanceinvitroandinanexvivomodel